Zobrazeno 1 - 10
of 110
pro vyhledávání: '"Htert mrna"'
Autor:
Daniel Gomes Henriques, Elisa Baranski Lamback, Aline Helen da Silva Camacho, Monique Alvares Barbosa, Debora Aparecida Silva, Alexandro Guterres, Liana Lumi Ogino, Mônica R. Gadelha, Leila Chimelli, Leandro Kasuki, Carlos Henrique de Azeredo Lima
Publikováno v:
Endocrine. 72:208-215
Non-functioning pituitary adenomas (NFPA) are benign tumors, however, some are agressive. We aimed to assess if human telomerase reverse transcriptase (hTERT) is present in NFPA and if it can be used as a marker of aggressiveness and proliferation. C
Autor:
María G. Picazo-Martínez, Ana B. Flores-Bautista, Ángela Díaz-Piqueras, Antonio S. Salinas-Sánchez, Syongh Y. Nam-Cha, Carlos Martínez-Sanchiz, Dolores C. García-Olmo, José M. Giménez-Bachs
Publikováno v:
Urologic Oncology: Seminars and Original Investigations. 37:749-757
Elevated mRNA expression of human telomerase reverse transcriptase (hTERT mRNA) is common in many types of tumors, participating in tumor growth and progression. Such expression has not been sufficiently examined in renal cancer. The goal of the pres
Autor:
S. Aliño-Pellicer, M.J. Herrero-Cervera, José María Martínez-Jabaloyas, J.A. March-Villalba, Jorge Panach-Navarrete
Publikováno v:
Actas Urológicas Españolas (English Edition). 42:524-530
Introduction To study the relationship between quantitative mRNA determination (hTERT) in patients with bladder tumor, history of bladder tumor, and in subjects without a history of this neoplasia. Material and methods A prospective randomized contro
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Annals of Oncology. 32:S372
Publikováno v:
Zdravniški Vestnik, Vol 71, Iss 0 (2002)
Background. Re-activation of the enzyme telomerase, has been detected in nearly 90% of human malignancies. In contrast, normal human somatic cells, with the exception of germ cells and stem cells of renewable tissues, do not have detectable telomeras
Externí odkaz:
https://doaj.org/article/4f27317c3c8a4dfea13d31226b8a2361
Autor:
Einat Beery, Shlomit Yust-Katz, Yoseph Laviv, Alexandra Amiel, Meir Lahav, Ramez Abu Shkara, Orit Uziel, Andrew A. Kanner, Tali Siegal
BACKGROUND: Primary glioblastoma multiforme (GBM) have a high proportion (~80%) of TERT-expressing tumors, indicating that this is the primary mechanism of telomerase (hTERT) activation. Exosomes are nano-sized secreted vesicles containing nucleic ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4886dcb1e9de88c30f115aeb4ffae29
https://europepmc.org/articles/PMC6216487/
https://europepmc.org/articles/PMC6216487/
Autor:
Shigeori Takenaka, Masaaki Kodama, Kazuhiro Tominaga, Mana Hayakawa, Irmina Diala, Kazuya Haraguchi, Shinobu Sato, Kumiko Tomoeda-Mori
Publikováno v:
Electroanalysis. 28:503-507
Electrochemical telomerase assay (ECTA) developed by our group was evaluated in an oral cancer screening using exfoliated oral cells and tissues obtained from patients of oral cancer, mucosa associated disease, or healthy volunteers. Telomerase activ
Autor:
Fuminori Miyoshi, Yoshitaka Ishihara, Noriaki Tanaka, Taro Yamashita, Yoshio Tanabe, Bingqiong Ping, Xinhui Wang, Toshihide Ogawa, Goshi Shiota, Keigo Miura, Tsutomu Matsuki, Satoshi Tsuno, Yuki Shinohara, Norimasa Miura
Publikováno v:
Cancer Medicine. 4:1603-1611
We have reported on the clinical usefulness of human telomerase reverse transcriptase (hTERT) mRNA quantification in sera in patients with several cancers. Positron emission tomography–computed tomography (PET/CT) using 18F-fluorodeoxyglucose (FDG)
Autor:
Orit Uziel, Ofir Wolach, Jardena Nordenberg, Meir Lahav, Ester Rabizadeh, Yonatan Edel, Anna Gutkin, Einat Beery, Hadar Goldvaser
Publikováno v:
British Journal of Cancer
Background: Telomerase (human telomerase reverse transcriptase (hTERT)) is considered a hallmark of cancer. The aim of our study was to evaluate the feasibility of the detection of hTERT transcripts in serum as a ‘pan-cancer’ diagnostic method. M